Literature DB >> 33484116

Severe oligomeric tau toxicity can be reversed without long-term sequelae.

Alfonso Martinisi1,2, Martin Flach1,2, Frederik Sprenger1,2, Stephan Frank1, Markus Tolnay1, David T Winkler1,2,3.   

Abstract

Tau is a microtubule stabilizing protein that forms abnormal aggregates in many neurodegenerative disorders, including Alzheimer's disease. We have previously shown that co-expression of fragmented and full-length tau in P301SxTAU62on tau transgenic mice results in the formation of oligomeric tau species and causes severe paralysis. This paralysis is fully reversible once expression of the tau fragment is halted, even though P301S tau expression is maintained. Whereas various strategies to target tau aggregation have been developed, little is known about the long-term consequences of reverted tau toxicity. Therefore, we studied the long-term motor fitness of recovered, formerly paralysed P301SxTAU62on-off mice. To assess the seeding competence of oligomeric toxic tau species, we also inoculated ALZ17 mice with brainstem homogenates from paralysed P301SxTAU62on mice. Counter-intuitively, after recovery from paralysis due to oligomeric tau species expression, ageing P301SxTAU62on-off mice did not develop more motor impairment or tau pathology when compared to heterozygous P301S tau transgenic littermates. Thus, toxic tau species causing extensive neuronal dysfunction can be cleared without inducing seeding effects. Moreover, these toxic tau species also lack long-term tau seeding effects upon intrahippocampal inoculation into ALZ17 mice. In conclusion, tau species can be neurotoxic in the absence of seeding-competent tau aggregates, and mice can clear these tau forms permanently without tau seeding or spreading effects. These observations suggest that early targeting of non-fibrillar tau species may represent a therapeutically effective intervention in tauopathies. On the other hand, the absent seeding competence of early toxic tau species also warrants caution when using seeding-based tests for preclinical tauopathy diagnostics.
© The Author(s) (2021). Published by Oxford University Press on behalf of the Guarantors of Brain.

Entities:  

Keywords:  Alzheimer’s disease; neurodegeneration; oligomers; seeding; tau

Year:  2021        PMID: 33484116     DOI: 10.1093/brain/awaa445

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  4 in total

1.  Selective disruption of Drp1-independent mitophagy and mitolysosome trafficking by an Alzheimer's disease relevant tau modification in a novel Caenorhabditis elegans model.

Authors:  Sanjib Guha; Anson Cheng; Trae Carroll; Dennisha King; Shon A Koren; Sierra Swords; Keith Nehrke; Gail V W Johnson
Journal:  Genetics       Date:  2022-08-30       Impact factor: 4.402

2.  Tau Cleavage Contributes to Cognitive Dysfunction in Strepto-Zotocin-Induced Sporadic Alzheimer's Disease (sAD) Mouse Model.

Authors:  Valentina Latina; Giacomo Giacovazzo; Pietro Calissano; Anna Atlante; Federico La Regina; Francesca Malerba; Marco Dell'Aquila; Egidio Stigliano; Bijorn Omar Balzamino; Alessandra Micera; Roberto Coccurello; Giuseppina Amadoro
Journal:  Int J Mol Sci       Date:  2021-11-10       Impact factor: 5.923

Review 3.  Liquid-Liquid Phase Separation Promotes Protein Aggregation and Its Implications in Ferroptosis in Parkinson's Disease Dementia.

Authors:  Mengzhu Li; Yaohua Fan; Qinglian Li; Xiaoling Wang; Lijun Zhao; Meiling Zhu
Journal:  Oxid Med Cell Longev       Date:  2022-10-06       Impact factor: 7.310

Review 4.  NLRP3 Inflammasome: A Starring Role in Amyloid-β- and Tau-Driven Pathological Events in Alzheimer's Disease.

Authors:  Mariana Van Zeller; Diogo Dias; Ana M Sebastião; Cláudia A Valente
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.